As of 2025-05-22, the Fair Value of Voyageur Pharmaceuticals Ltd (VM.V) is -0.06 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.17 CAD, the upside of Voyageur Pharmaceuticals Ltd is -137.31%.
With the market price of 0.17 CAD and our fair value calculation, Voyageur Pharmaceuticals Ltd (VM.V) is not a good investment. Investing in VM.V stocks now will result in a potential loss of 137.31%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-11-30 | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | 5Y Avg | |
| Net income | -1.14 | -2.05 | -1.75 | -1.40 | -1.71 | -1.61 |
| YoY growth | -106.31% | -80.05% | 14.51% | 20.21% | -21.99% | -34.73% |
| Market Cap (mil) | 27.29 |
| P/E | |
| Forward P/E |
| EPS | -0.01 |
| Avg earnings growth rate | -34.73% |
| TTM earnings | -2.04 |